According to French media reports, Eli Lilly and AstraZeneca are interested in acquiring the biotech company Abivax in a deal that could be worth up to EUR 15bn.
发布者:BY PHILIP MADSEN,转转请注明出处:https://robotalks.cn/french-biotech-abivax-named-among-europes-hottest-acquisition-targets-in-2026/